Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers

Chen, Y; Chi, P

Chi, P (reprint author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.; Chi, P (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Chi, P (reprint author), Weill Cor

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018; 11 ():

Abstract

Unlike many conventional cancers with preferential patterns of oncogenic genetic alterations, TRK fusions resulting from NTRK1/2/3 genetic alterations......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索